Frontotemporal dementia

Seminars in Neurology

Volumn 27, Issue 1, 2007, Pages 48-57

  Graff Radford, Neill R ^a   Woodruff, Bryan K ^b  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Frontotemporal dementia; Pick's disease; Primary progressive aphasia; Tau; Ubiquitin

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; MEMANTINE; MICROTUBULE ASSOCIATED PROTEIN; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR; TAU PROTEIN; TRAZODONE; UBIQUITIN;

BEHAVIOR DISORDER; CELL INCLUSION; CHROMOSOME 17; CORTICOBASAL DEGENERATION; DEGENERATIVE DISEASE; FRONTOTEMPORAL DEMENTIA; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; HUMAN; MOTOR NEURON DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; PRIMARY PROGRESSIVE APHASIA; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

APHASIA, PRIMARY PROGRESSIVE; BRAIN; CHROMOSOMES, HUMAN, PAIR 17; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; HUMANS; INCLUSION BODIES; PICK DISEASE OF THE BRAIN; TAU PROTEINS;

EID: 33846934718     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-956755     Document Type: Review

References (34)

1. Pick A. Ueber die Beziehungen der senilen Hirnatrophie zur Aphasia. Prag Med Wochenschr 1892;17:165-167
2. Alzheimer A. Uber eigenartige Krankheitsfalle des spateren Alters. Z Ges Neurol Psychiatr 1911;4:356-385
3. Onari K, Spatz H. Anatomische Beitrage zur Lehre von der Pickschen umschriebenen Grosshirnrinden-Atrophie ("Picksche Krankheit"). Z Ges Neurol Psychiatr 1926;101:470-511
4. Mesulam MM. Slowly progressive aphasia without generalized dementia. Ann Neurol 1982;11:592-598
5. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51:1546-1554
6. Knopman DS, Petersen RC, Edland SD, Cha RH, Rocca WA. The incidence of frontotemporal lobar degeneration in Rochester, Minnesota, 1990 through 1994. Neurology 2004;62:506-508
7. Warren JD, Schott JM, Fox NC, et al. Brain biopsy in dementia. Brain 2005;128:2016-2025
8. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51:1546-1554
9. Kertesz A, Munoz D. Pick's disease, frontotemporal dementia, and Pick complex: emerging concepts. Arch Neurol 1998;55:302-304
10. McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol 2001;58:1803-1809
11. Kent RD, Duffy JR, Slama A, Kent JF, Clift A. Clinicoanatomic studies in dysarthria: review, critique, and directions for research. J Speech Lang Hear Res 2001;44:535-551
12. Mesulam MM. Primary progressive aphasia. Ann Neurol 2001;49:425-432
13. Le Rhun E, Richard F, Pasquier F. Natural history of primary progressive aphasia. Neurology 2005;65:887-891
14. Hutton M. Molecular genetics of chromosome 17 tauopathies. Ann NY Acad Sci 2000;920:63-73
15. Foster NL, Wilhelmsen K, Sima AA, Jones MZ, D'Amato CJ, Gilman S. Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. Conference Participants. Ann Neurol 1997;41:706-715
16. Reed LA, Wszolek ZK, Hutton M. Phenotypic correlations in FTDP-17. Neurobiol Aging 2001;22:89-107
17. Strong MJ, Lomen-Hoerth C, Caselli RJ, Bigio E, Yang W. Cognitive impairment, frontotemporal dementia, and the motor neuron diseases. Ann Neurol 2003;54(suppl 5):S20-S23
18. Boeve BF, Maraganore DM, Parisi JE, et al. Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology 1999;53:795-800
19. Josephs KA, Petersen RC, Knopman DS, et al. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology 2006;66:41-48
20. Pasquier F, Fukui T, Sarazin M, et al. Laboratory investigations and treatment in frontotemporal dementia. Ann Neurol 2003;54(suppl 5):S32-S35
21. Whitwell JL, Jack CR Jr, Senjem ML, Josephs KA. Patterns of atrophy in pathologically confirmed FTLD with and without motor neuron degeneration. Neurology 2006;66:102-104
22. Short RA, Broderick DF, Patton A, Arvanitakis Z, Graff-Radford NR. Different patterns of magnetic resonance imaging atrophy for frontotemporal lobar degeneration syndromes. Arch Neurol 2005;62:1106-1110
23. Constantinidis J, Richard J, Tissot R. Pick's disease: histological and clinical correlations. Eur Neurol 1974;11:208-217
24. Goedert M. Introduction to the tauopathies. In: Dickson D, ed. Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders. Basel: ISN Neuropath Press; 2003:82-85
25. Munoz DG, Dickson DW, Bergeron C, Mackenzie I, Delacourte A, Zhukareva V. The neuropathology and biochemistry of frontotemporal dementia. Ann Neurol 2003;54(suppl 5):S24-S28
26. Knopman DS, Mastri AR, Frey WH II, Sung JH, Rustan T. Dementia lacking distinctive histologic features: a common non-Alzheimer degenerative dementia. Neurology 1990;40:251-256
27. Rademakers R, Cruts M, Dermaut B, et al. Tau negative frontal lobe dementia at 17q21: significant finemapping of the candidate region to a 4.8 cM interval. Mol Psychiatry 2002;7:1064-1074
28. Skibinski G, Parkinson NJ, Brown JM, et al. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat Genet 2005;37:806-808
29. Hosler BA, Siddique T, Sapp PC, et al. Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21-q22. JAMA 2000;284:1664-1669
30. Kovach MJ, Waggoner B, Leal SM, et al. Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementia. Mol Genet Metab 2001;74:458-475
31. Rademakers R, Melquist S, Cruts M, et al. High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy. Hum Mol Genet 2005;14:3281-3292
32. Pittman AM, Myers AJ, Abou-Sleiman P, et al. Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration. J Med Genet 2005;42:837-846
33. Graff-Radford N. Presenilin mutations: variations in the behavioral phenotype with an emphasis on the frontotemporal dementia phenotype. In: Cummings J, Hardy J, Poncet M, Christen Y, eds. Genotype-Proteotype-Phenotype Relationships on Neurodegenerative Diseases. Berlin: Springer-Verlag; 2005:93-101
34. Hutton M, Lewis J, Dickson D, Yen SH, McGowan E. Analysis of tauopathies with transgenic mice. Trends Mol Med 2001;7:467-470